A combination with clinical recommended dosages of salmeterol and ipratropium is not more effective than salmeterol alone in patients with chronic obstructive pulmonary disease
- 30 September 1996
- journal article
- clinical trial
- Published by Elsevier in Respiratory Medicine
- Vol. 90 (8) , 497-499
- https://doi.org/10.1016/s0954-6111(96)90178-x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- A comparison of the bronchodilating effects of salmeterol, salbutamol and Ipratropium bromide in patients with chronic obstructive pulmonary diseasePulmonary Pharmacology, 1995
- Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response studyRespiratory Medicine, 1995
- Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.Thorax, 1995
- Effect of Salmeterol and Formoterol in Patients with Chronic Obstructive Pulmonary DiseasePulmonary Pharmacology, 1994
- Studies on the Interaction between Formoterol and Salmeterol in Guinea‐Pig Tracheain VitroBasic & Clinical Pharmacology & Toxicology, 1992
- Modulation of neurotransmission in airwaysPhysiological Reviews, 1992
- Effects of Procaterol, a Beta-2-Adrenoceptor Stimulant, on Neuroeffector Transmission in Human Bronchial TissueRespiration, 1991
- Effects of adrenergic agonists and adenosine on cholinergic neurotransmission in human tracheal smooth musclePulmonary Pharmacology, 1989
- Statement on Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease (COPD) and AsthmaAmerican Review of Respiratory Disease, 1987